OAK RIDGE INVESTMENTS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
OAK RIDGE INVESTMENTS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,108,000
-17.7%
31,248
-21.1%
0.27%
-6.8%
Q3 2020$3,775,000
-41.0%
39,598
-30.8%
0.29%
-45.3%
Q2 2020$6,400,000
+42.3%
57,214
-7.5%
0.54%
+16.5%
Q1 2020$4,499,000
-38.3%
61,873
-11.6%
0.46%
-13.8%
Q4 2019$7,297,000
-6.6%
69,966
-10.9%
0.54%
-9.0%
Q3 2019$7,812,000
-39.4%
78,487
-30.5%
0.59%
-34.0%
Q2 2019$12,887,000
-18.5%
112,902
-10.3%
0.89%
-11.4%
Q1 2019$15,819,000
-41.6%
125,841
-37.0%
1.01%
-48.4%
Q4 2018$27,109,000
-53.3%
199,768
-5.6%
1.95%
-39.2%
Q3 2018$58,095,000
+24.0%
211,648
-6.4%
3.21%
+20.8%
Q2 2018$46,848,000
+14.8%
226,134
-8.5%
2.66%
+17.2%
Q1 2018$40,825,000
-7.1%
247,182
-23.0%
2.26%
+8.0%
Q4 2017$43,964,000
-26.1%
321,072
-26.5%
2.10%
-13.1%
Q3 2017$59,458,000
-13.5%
436,708
-22.9%
2.42%
+10.2%
Q2 2017$68,725,000
+13.8%
566,102
-0.8%
2.19%
+8.1%
Q1 2017$60,388,000
-10.9%
570,555
-14.5%
2.03%
-7.7%
Q4 2016$67,783,000
-18.0%
667,093
-17.6%
2.20%
+2.4%
Q3 2016$82,671,000
-20.1%
810,022
-6.6%
2.15%
-19.3%
Q2 2016$103,490,000
-48.7%
867,695
-53.9%
2.66%
+2.7%
Q1 2016$201,650,000
+94.6%
1,882,986
+97.0%
2.59%
+4.4%
Q4 2015$103,606,000
+26.2%
955,599
-0.3%
2.48%
+26.7%
Q3 2015$82,108,000
+67.8%
958,644
+97.7%
1.96%
+88.5%
Q2 2015$48,933,000
+40.6%
484,973
+7.5%
1.04%
+33.2%
Q1 2015$34,801,000451,3110.78%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders